EverPoint Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14.4M Buy
100,000
+50,000
+100% +$6.69M 0.27% 103
2016
Q3
$6.27M Buy
+50,000
New +$6.46M 0.11% 211
2016
Q2
Sell
-90,000
Closed -$12.5M 417
2016
Q1
$12.5M Buy
90,000
+60,000
+200% +$8.02M 0.25% 109
2015
Q4
$4.18M Buy
+30,000
New +$4.13M 0.09% 274
2015
Q3
Sell
-65,000
Closed -$10.7M 438
2015
Q2
$10.7M Buy
+65,000
New +$10.4M 0.19% 159
2015
Q1
Sell
-97,000
Closed -$12.2M 525
2014
Q4
$12.2M Buy
+97,000
New +$12M 0.27% 119

Other funds holding ELV

EverPoint Asset Management's ELV Position: Q4 2016 in Review

EverPoint Asset Management increased its Elevance Health (ELV) stake by 100% in Q4 2016, buying an estimated $6.69M and bringing the position to 100,000 shares worth $14.4M. The position accounts for 0.27% of the portfolio, ranked #103.

EverPoint Asset Management first reported a position in ELV in Q4 2014 and has held it in 6 quarters since. 784 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • EverPoint Asset Management held 100,000 shares of Elevance Health worth $14.4M as of Q4 2016.
  • EverPoint Asset Management bought 50,000 Elevance Health shares in Q4 2016, an estimated $6.69M.
  • Elevance Health made up 0.27% of EverPoint Asset Management's portfolio in Q4 2016, its #103 holding.
  • EverPoint Asset Management first reported a position in Elevance Health in Q4 2014 and has held it in 6 quarters since.
  • 784 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.